Abstract
Nocturnal hypoxemic burden is established as a robust prognostic metric of sleep-disordered breathing (SDB) to predict mortality and treating hypoxemic burden may improve prognosis. The aim of this study was to evaluate improvements in nocturnal hypoxemic burden using transvenous phrenic nerve stimulation (TPNS) to treat patients with central sleep apnea (CSA). The remedē System Pivotal Trial population was examined for nocturnal hypoxemic burden. The minutes of sleep with oxygen saturation < 90% significantly improved in Treatment compared with control (p
Author supplied keywords
Cite
CITATION STYLE
Oldenburg, O., Costanzo, M. R., Germany, R., McKane, S., Meyer, T. E., & Fox, H. (2021). Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea. Journal of Cardiovascular Translational Research, 14(2), 377–385. https://doi.org/10.1007/s12265-020-10061-0
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.